cancer - search results

Dr Eva Steliarova, Scientist at IARC’s Section of Cancer Surveillance explains how research results can be used to reduce the burden of cancer in children

Sumith A Kularatne, Vice President of Research & Development at On Target Laboratories discusses the scope of image-guided surgery in treating lung cancer

Sumith A Kularatne of On Target Laboratories, LLC highlights cancer immunotherapy as the treatment of the year to target cancer cells

There are many challenges associated with identifying potentially cancerous pancreatic cysts. Here, Dr. Annabelle L. Fonseca et al explain

Scientists have warned that antimicrobial resistance could overtake cancer when it comes to the number of deaths per year

Dr Alla Reznik, Canada Research Chair in Physics of Medical Imaging, explains how Positron Emission Mammography is effective when detecting breast cancer

Professor Roberto Cerbino of the University of Milan discusses how cell tissues may be ruled by the same laws of jammed inert particles

The Cancer Drugs Fund, set up to pay for medication not funded by the NHS, was a “huge waste of money” and caused unnecessary suffering for patients

Canadian Cancer Society’s Dr Rob Nuttall and Shawn Chirrey explain how fighting against breast cancer requires ongoing support for research and screening

A mechanism used by breast cancer cells to grow and spread has been discovered. This has the potential to open the way for a new generation of treatments

AIRC is involved in financing cancer research in Italy, helping researchers produce quality projects. Professor Federico Caligaris Cappio explains

On Target Laboratories' Dr Sumith A. Kularatne shares his research into targeted drugs and notes the difference this treatment makes to cancer patients

During the past 30 years it has become exceedingly clear that several viruses play significant roles in the development of various cancers in humans

Zhihui Wang and Vittorio Cristini provide evidence that could improve the success of treatment plans and make predicting cancer treatment outcome easier Current processes for creating cancer treatment plans are primarily based on empirical data from clinical trials, consensus expert panel guidelines, and limited laboratory-based testing. Physicians still face major...

Mathias Heikenwälder at the German Cancer Research Center warns of the impact of modern lifestyles and the obesity epidemic on liver cancer and metastasis Alterations in lifestyles over the last decades, including high caloric diets combined with sedentarism, have increased the worldwide incidence of overweight and metabolic syndrome, characterised by...

Can we prevent the muscle loss associated with some cancers? Dr Vera Mazurak at the University of Alberta is looking into one method of treating myosteatosis Pathological fat infiltration into muscle is a feature of disease-induced muscle loss that significantly associates with shorter survival in people with cancer. Fat is...

IARC’s Véronique Terrasse highlights the link between the growing obesity epidemic and cancer in countries around the world, with some alarming statistics The obesity epidemic is reaching alarming proportions in many countries and has become a major public health concern in both developed and low and middle-income countries (LMICs). Indeed, the...

Open Access Government spoke to the National Cancer Institute’s Dr S Percy Ivy about cancer research and training and the importance of clinical trials The National Cancer Institute (NCI) is one of 27 institutes that make up the National Institutes of Health (NIH). The NCI is the US federal government’s...

New avenues are opening up for treatment of gynaecological cancer, Professor Gunnar Kristensen of Oslo University Hospital explains to Open Access Government Surgery remains an important step in the treatment of ovarian cancer. Two earlier randomised studies revealed the same survival rates for patients who had surgery as the first...

Dr Sumith A Kularatne, vice-president of R&D at On Target Laboratories, explores the pros and cons of various existing treatments for prostate cancer Prostate cancer (PCa) is the second leading cause of cancer-related deaths in men, with about 1.1 million new cases and approximately 307,000 fatalities per year globally. This...